baber/WOPTO huggingface dataset:
Patent AU-2009279989-B2 (AU)
Title: Push filter with floating key lock
Inventor: HUDA STEPHEN P
IPC: B01D35/30
Filed: 2009-07-15
Granted: 2013-11-28
Abstract: A filter assembly for fluid filtration having a push-activated lock and release mechanism. A push filter design activates a floating key lock upon insertion and extraction, where the filter key may be used simultaneously as a lock and as an identifier for particular filter attributes. The filter base may be situated inline, and in fluid communication, with influent and effluent piping, such as within a refrigerator. The filter housing assembly may be attached to, and removed from, the filter base by a push-actuated release. Upon insertion, the filter key shifts the filter lock longitudinally to receive interlocking segments. Upon extraction, the same axial push shifts the filter lock further to align the interlocking fingers within gaps that allow for easy extraction. The specific key lock design allows a user to identify and match certain filter configurations received by the mechanical support, and reject other filter configurations.
Patent AU-2009320150-B2 (AU)
Title: Wad with ignition chamber
Inventor: SCHLUCKEBIER DAVID K
IPC: F42B7/08
Filed: 2009-10-27
Granted: 2014-09-25
Abstract: A wad or basewad (11) for ammunition includes an ignition chamber (26). The ignition chamber (26) can be integrally formed with the wad or basewad (11) or can be attached to the wad or basewad (11). The ignition chamber (11) communicates with a primer (18) of the ammunition to receive and contain the primer blast for at least an initial period of time. This facilitates faster initial ignition of the propellant of the ammunition, and consequently allows higher performance levels to be achieved. Other advantages regarding other applications of this invention include cleaner burning loads, greater economy, and lower perceived recoil.
Patent AU-2009333580-B2 (AU)
Title: Anti-PD-L1 antibodies and their use to enhance T-cell function
Inventor: IRVING BRYAN
IPC: C07K16/28
Filed: 2009-12-08
Granted: 2016-07-07
Abstract: The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (
Patent AU-2010202657-B2 (AU)
Title: A drive for a cutting or grinding machine
Inventor: STRATTI TROY
IPC: F16C3/03
Filed: 2010-06-25
Granted: 2013-03-28
Abstract: A drive for a grinding or cutting machine comprising a body having a drive coupling for receiving at least one drive shaft in a manner so that the or each drive shaft is drivable by the drive. The drive also comprises a mount for mounting the body to a portion of the machine such as to a linkage arm of an earth grinding or cutting vehicle. The drive coupling is arranged to inter-fit with a portion of the or each drive shaft.
Patent AU-2010213932-B2 (AU)
Title: Intermediate vapor collection within encapsulated control infrastructures
Inventor: DANA TODD
IPC: C10G1/04
Filed: 2010-02-08
Granted: 2013-05-02
Abstract: A method of recovering hydrocarbons from hydrocarbonaceous materials can include forming a constructed permeability control infrastructure (600). This constructed infrastructure (600) defines a substantially encapsulated volume. A mined hydrocarbonaceous material can be introduced into the control infrastructure to form a permeable body (605) of hydrocarbonaceous material. The permeable body (605) can be heated sufficient to remove hydrocarbons therefrom. Hydrocarbon products can be collected from intermediate locations (620, 630) within the permeable body (605). Advantageously, an intermediate fluid collection system (610) can be used to draw a hydrocarbon product from the permeable body (605) at preselected locations. Such intermediate collection can provide hydrocarbon product fractions which can reduce or eliminate the need for full-scale distillation of a hydrocarbon product having a full range of products such as that typically found in crude oil. In addition, product quality can be tailored by monitoring such intermediate draws and adjusting operating parameters accordingly.
Patent AU-2010221833-B2 (AU)
Title: Method for separating neutral and polar lipids and an oil rich in polar lipids
Inventor: HARROD MAGNUS
IPC: C11B7/00
Filed: 2010-03-10
Granted: 2015-05-07
Abstract: A method for separating neutral and polar lipids from an oil of biological material, wherein the oil is fractionated using a mixture of a polar solvent comprising at least one carbon atom, water and an additional substance selected from the group consisting of: mono-, di- and oligosaccharides comprising from 3 to 10 monosaccharide units, said additional substance is present in an amount of at least 0,1 wt% calculated on the total weight of solvent, water and additional substance, to form at least two liquid fractions having different densities, wherein one fraction is rich in polar lipids and another fraction is rich in neutral lipids. An oil rich in polar lipids obtained from the method is disclosed, said oil I contains at least 40, preferably at least 50 lipid% polar lipids as calculated on the total amount of lipids in said oil and that the total amount of polar solvent and water in said oil is between 20 and 30 wt%. An oat oil containing high amounts of estolides of DGDG can further be obtained.
Patent AU-2010236057-B2 (AU)
Title: Wagering game for awarding attributes in a plurality of plays
Inventor: GOMEZ BENJAMIN T
IPC: A63F13/10
Filed: 2010-10-27
Granted: 2013-02-07
Abstract: A method for conducting a computer-implemented wagering game includes using a processor to execute a plurality of plays of the wagering game, each play having an expected value. A plurality of randomly selected symbols, which are associated with each play, are displayed on a display. The processor is used to randomly assign a plurality of attributes across the plurality of plays. Each attribute increases an expected value of the play to which the attribute is assigned, from a first value to a second value. The first value is in the absence of the attribute and the second value is in the presence of the attribute. 420 5/14 514 MULTI-LEVEL PROGRESSIVES DIAMOND LEVEL $1,500.00 SAPPHIRE LEVEL $500.00 EMERALD LEVEL $50.00 522> BONUSA BONUS B DIAMOND LEVEL 89 FREE SPINS DIAMOND LEVEL 24 EXTRA WILDS SAPPHIRE LEVEL 25 FREE SPINS SAPPHIRE LEVEL 12 EXTRA WILDS EMERALD LEVEL 12 FREE SPINS EMERALD LEVEL 4 EXTRA WILDS BONUS TYPE A-FREE SPINS BONUS TYPE B-EXTRA WILD SYMBOLS DURING FREE SPINS BONUS C BONUSD DIAMOND LEVEL 30x MULTIPLIER DIOND LEVEL 2,500 CREDITS SAPPHIRE LEVEL 21 X MULTIPLIER SAPPHIRE LEVEL 1,200 CREDITS EMERALD LEVEL 8x MULTIPLIER EMERALD LEVEL 750 CREDITS BONUS TYPE C-EXTRA MULTIPLIER BONUS TYPE D-CREDIT PRIZE AWARDED IN BONUS
Patent AU-2010246504-B2 (AU)
Title: Methods and kits for diagnosing tumorigenicity
Inventor: GINETTE SERRERO
IPC: G01N33/53
Filed: 2010-11-29
Granted: 2011-09-22
Abstract: A method for diagnosing tumorigenicity comprising: measuring the level of GP88 protein in a first biological fluid taken from a patient; measuring the level of GP88 protein in a second biological fluid taken from said patient; and diagnosing tumorigenicity by determining whether the measured level of GP88 protein in said second biological fluid is higher than the level in said first biological fluid by an amount sufficient to indicate tumorigenicity. 0 5 10 15 25 PCDGF( )
Patent AU-2010263365-B2 (AU)
Title: Method for isolation and quantification of naphthenate forming acids ("ARN acids") in crude oil
Inventor: MEDIAAS HEIDI
IPC: C10G25/00
Filed: 2010-06-22
Granted: 2015-02-05
Abstract: A method for isolation and quantification of naphthenate forming acids (ARN-acids) in crude oils is disclosed. The method involves selective absorbtion/adsorption of ARN acids by a solid medium. Isolation of the solid medium and transferring the ARN acids to an organic solvent which can by analysed for its ARN acid content.
Patent AU-2010273449-B2 (AU)
Title: Method and apparatus for separating biological materials
Inventor: LEACH MICHAEL D
IPC: A61M1/36
Filed: 2010-07-14
Granted: 2015-07-16
Abstract: According to various embodiments, a system can be provided to separate undifferentiated cells and/or stromal cells from a whole tissue sample. The whole tissue sample can be any appropriate tissue sample obtained directly from a patient. The tissue sample can be obtained during a selected operating procedure for immediate or quick application or re-application to the patient. Accordingly, autologous cells can be obtained intraoperatively for application to a patient substantially soon after obtaining a whole tissue sample.
Patent AU-2010283613-B2 (AU)
Title: FGF receptor-activating N-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
Inventor: DUCHAUSSOY PHILIPPE
IPC: C07H15/203
Filed: 2010-08-12
Granted: 2016-03-10
Abstract: The invention relates to FGF receptor-activating N-sulfate oligosaccharides having Formula (I), wherein R
Patent AU-2010320911-B2 (AU)
Title: Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder
Inventor: JOMARD ANDRE
IPC: A61P17/06
Filed: 2010-11-18
Granted: 2013-09-12
Abstract: Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an α2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.
Patent AU-2010357244-B2 (AU)
Title: Mixed beverage preparation and dispensing
Inventor: SCHOLVINCK MICHIEL OLIVIER
IPC: B67D1/12
Filed: 2010-07-14
Granted: 2015-11-26
Abstract: A water dispensing device comprises water dispensing means for dispensing water into a serving container. The device furthermore comprises a control unit which is connected with the water dispensing means to control a water dispensing cycle in which a predetermined amount of water is dispensed in the serving container. The control unit is programmed such that the water dispensing cycle includes at least two stages which are separated by an intermediate time period in which no water is dispensed in the serving container.
Patent AU-2011202239-B2 (AU)
Title: Long-acting formulations of insulins
Inventor: BECKER REINHARD
IPC: A61K38/16
Filed: 2011-05-16
Granted: 2012-06-07
Abstract: Sanofi-Aventis DE2010/103 Dr. OUBa Abstract 5 Long - acting formulations of insulins The application relates to an aqueous pharmaceutical formulation comprising 200 1000 U/mL [equimolarto 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, 0 and its use. oo (D~ cuc o C.) oID * - o UJ) -o.. OE C - O u..
Patent AU-2011217569-B2 (AU)
Title: Method and UHT installation for treating heat-sensitive liquid food products
Inventor: KOWALIK MANFRED
IPC: A23C3/037
Filed: 2011-01-21
Granted: 2014-09-18
Abstract: The invention relates to a method for treating heat-sensitive liquid food products (P), in particular a dairy product such as milk, cream, or whey protein concentrate, in a UHT installation (1) according to the preamble of claim 1. In a UHT installation, the basic design of which using an infusion chamber is described in [4], the aim of the invention is to ensure a uniform and constant residence time and a uniform and constant temperature curve for all of the treated food product downstream of an outlet of a device in which the food product is subjected to direct heating by the supply of steam, and to minimise fouling when the food product is being kept hot in said region. This is achieved by the method in that the heated food product (P*) undergoes a predetermined pressure increase (Δp) upstream of the point at which it is kept hot at a predetermined unchangeable location, and in that the pressure level upstream of the relaxation location is above the pressure level upstream of the location before the pressure increase (Δp).
Patent AU-2011225122-B2 (AU)
Title: Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
Inventor: MIYAZAKII HIDEKAZU
IPC: C07D401/12
Filed: 2011-03-11
Granted: 2013-11-07
Abstract: Disclosed is a compound containing pyridine ring that can be advantageously synthesized industrially. Also disclosed is an industrially advantageous method for producing the compound represented by formula (1) containing a pyridine ring, this compound being useful as an intermediate for producing tetrazolyloxime derivatives that exhibit bactericidal activity. The method also industrially produces 2-substituted amino-6-halomethylpyridine derivatives and tetrazolyloxime derivatives advantageously. (In the formula, R
Patent AU-2011229482-B2 (AU)
Title: Method for production of polymer containing fibres
Inventor: BAUSCH ANDREAS
IPC: D01F1/02
Filed: 2011-03-16
Granted: 2015-05-07
Abstract: The present invention relates to a method of spinning a polypeptide polymer containing fibre. It further relates to a polymer fibre obtainable by said method and to uses thereof. The invention also relates to products comprising said polymer fibre.
Patent AU-2011231244-B2 (AU)
Title: Plug space plug filter with flavor bead
Inventor: ALLEN JEFFREY LYNN
IPC: A24D3/06
Filed: 2011-03-28
Granted: 2015-06-25
Abstract: A filter component (220) for a smoking article (200) includes an upstream segment (230) of filter material; a downstream segment (240) of filter material in a spaced apart relation to the upstream segment (230) of filter material so as to define a cavity (250) therebetween, and a single flavor bead (260) disposed in the cavity (250). The flavor bead comprises tobacco particles and water and has (260) an outer diameter, which is at least 75% of the spaced apart relation of the upstream segment (230) of filter material and the downstream segment (240) of filter material. The outer diameter of the flavor bead (260) does not exceed an outer diameter of either the upstream or downstream segments (230, 240) of filter material.
Patent AU-2011245438-B2 (AU)
Title: Azeotropic and azeotrope-like compositions of E-1,1,1,4,4,4-hexafluoro-2-butene
Inventor: ROBIN MARK L
IPC: C09K5/04
Filed: 2011-04-26
Granted: 2015-08-20
Abstract: Azeotropic or azeotrope-like compositions are disclosed. The azeotropic or azeotrope-like compositions are mixtures of E-1,1,1,4,4,4-hexafluoro-2-butene with E-1-chloro-3,3,3-trifluoropropene or 2-chloro-3,3,3-trifluoropropene. Also disclosed is a process of preparing a thermoplastic or thermoset foam by using such azeotropic or azeotrope-like compositions as blowing agents. Also disclosed is a process of producing refrigeration by using such azeotropic or azeotrope-like compositions. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as solvents. Also disclosed is a process of producing an aerosol product by using such azeotropic or azeotrope-like compositions. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as heat transfer media. Also disclosed is a process of extinguishing or suppressing a fire by using such azeotropic or azeotrope-like compositions. Also disclosed is a process of using such azeotropic or azeotrope-like compositions as dielectrics.
Patent AU-2011264975-B2 (AU)
Title: Neural modulation devices and methods
Inventor: TWEDEN KATHERINE S
IPC: A61N1/36
Filed: 2011-06-08
Granted: 2015-03-12
Abstract: A system for designing a therapy or for treating a gastrointestinal disorder or a condition associated with excess weight in a subject comprising at least one electrode configured to be implanted within a body of the patient and placed at a vagus nerve, the electrode also configured to apply therapy to the vagus nerve upon application of a therapy cycle to the electrode; an implantable neuroregulator for placement in the body of the patient beneath the skin layer, the implantable neuroregulator being configured to generate a therapy cycle, wherein the therapy cycle comprises an on time during which an electrical signal is delivered, the electrical signal comprising: a) a set of pulses applied at a first selected frequency of about 150-10,000 Hz, wherein each pulse of the set of pulses has a pulse width of at least 0.01 milliseconds and less than the period of the first selected frequency.
Patent AU-2011269353-B2 (AU)
Title: Process for removing, isolating and purifying dicarboxylic acids
Inventor: TIETZ WOLFGANG
IPC: C12P7/46
Filed: 2011-05-31
Granted: 2015-04-02
Abstract: A process for removing, isolating and purifying dicarboxylic acid from fermentation broths, which comprises the following steps: f) removal of the biomass and any solids present from the fermentation broth in two successive stages, g) removal of the dicarboxylic acid solution from the biomass-free fermentation broth by simulated moving bed (SMB) chromatography, h) fine purification of the dicarboxylic acid solution, i) multistage evaporative concentration and crystallization, j) separation and drying of the crystals.
Patent AU-2011274528-B2 (AU)
Title: Anti-neuropilin antibodies and methods of use
Inventor: SCHMIDT MAIKE
IPC: C07K16/28
Filed: 2011-07-08
Granted: 2015-04-23
Abstract: The invention provides anti-NRP1 antibodies and methods of using the same.
Patent AU-2011279513-B2 (AU)
Title: Evaporative heat exchange apparatus with finned elliptical tube coil assembly
Inventor: BUGLER THOMAS WILLIAM
IPC: F28F1/02
Filed: 2011-07-08
Granted: 2015-02-26
Abstract: An improved finned coil tube assembly (24, 24A, 24B, 24C, 24D) enhances evaporative heat exchanger (26, 26A, 26B, 26C, 26D) performance, and includes tubes (10), preferably serpentine tubes, in the coil assembly. The tubes have a generally elliptical cross-section with external fins (20) formed on an outer surface of the tubes. The fins are spaced substantially 1.5 to substantially 3.5 fins per inch (2.54 cm) along the longitudinal axis (13) of the tubes, extend substantially 23.8% to substantially 36% of the nominal tube outside diameter in height from the tubes outer surface and have a thickness of substantially 0.007 inch (0.018 cm) to substantially 0.020 inch (0.051 cm). The tubes have a center-to-center spacing (DH) generally horizontally and normal to the longitudinal axis of the tubes of substantially 109% to substantially 125% of the nominal tube outside diameter, and a generally vertical center-to-center spacing (Dv) of substantially 100% to about 131 % of the nominal tube outside diameter.
Patent AU-2011283134-B2 (AU)
Title: Cryogenic systems for removing acid gases from a hydrocarbon gas stream using co-current separation devices
Inventor: NORTHROP PAUL SCOTT
IPC: F25J3/00
Filed: 2011-06-28
Granted: 2014-04-24
Abstract: A system for removing acid gases from a raw gas stream is provided. The system includes a cryogenic distillation column. The cryogenic distillation column receives a dehydrated and chilled sour gas stream, and separates the sour gas stream into an overhead gas stream comprised primarily of methane, and a bottom acid gas stream comprised primarily of carbon dioxide. The system also includes a series of co-current contactors. The co-current contactors may be placed in series to receive the bottom acid gas stream and recapture any entrained methane gas. Alternatively or in addition, the co-current contactors may be placed in series to receive the overhead gas stream, and sweeten it using a reflux liquid such as methane. In this instance, the sweetened gas is optionally liquefied and delivered for commercial sale, or is used as fuel gas on-site.
Patent AU-2011305575-B2 (AU)
Title: Transpose boxes for network interconnection
Inventor: MARR MICHAEL DAVID
IPC: G06F15/16
Filed: 2011-09-20
Granted: 2014-10-16
Abstract: The deployment and scaling of a network of electronic devices can be improved by utilizing one or more network transpose boxes. Each transpose box can include a number of connectors and a meshing useful for implementing a specific network topology. When connecting devices of different tiers in the network, each device need only be connected to at least one of the connectors on the transpose box. The meshing of the transpose box can cause each device to be connected to any or all of the devices in the other tier as dictated by the network topology. When changing network topologies or scaling the network, additional devices can be added to available connectors on an existing transpose box, or new or additional transpose boxes can be deployed in order to handle the change with minimal cabling effort.
Patent AU-2011319442-B2 (AU)
Title: Assemblable disposable shuttering for constructing modular formworks for making concrete foundations
Inventor: MARTIGLI MASSIMO
IPC: E02D27/02
Filed: 2011-05-13
Granted: 2016-09-15
Abstract: Assemblable disposable shuttering, for constructing modular formworks suitable for making foundations, said shuttering substantially configured as the lateral surface of a parallelepiped, having on the lateral faces a plurality of openings suitable toe release, during the filling casting, a part of the cement mixture into the foundation trench.
Patent AU-2011326386-B2 (AU)
Title: Method of providing a source of potable water
Inventor: LIANG LI-SHIANG
IPC: C25B15/02
Filed: 2011-11-11
Granted: 2015-09-03
Abstract: An electrical purification apparatus and methods of making same are disclosed. The electrical purification apparatus may provide for increases in operation efficiencies, for example, with respect to current efficiencies and membrane utilization.
Patent AU-2011358083-B2 (AU)
Title: Method for culturing human pluripotent stem cells
Inventor: FURUE MIHO
IPC: C12N5/10
Filed: 2011-08-24
Granted: 2016-04-21
Abstract: The present invention addresses the problem of providing: a method for culturing human pluripotent stem cells still remaining in an undifferentiated state, and a kit to be used with the method, the method being more efficient than conventional methods. It has been confirmed that the pluripotency of stem cells is efficiently maintained, irrespective of how proficient an experimenter is in regard to culturing techniques, in a case where: (a) human pluripotent stem cells are cultured in a first medium, which is a pluripotent stem cell medium including activin; (b) the first culture is replaced with a second culture, which is an activin-free pluripotent stem cell medium, and the human pluripotent stem cells are cultured; (c) the human pluripotent stem cells are sub-cultured in the first medium; and thereafter (b) and (c) are repeated in the stated order.
Patent AU-2011383612-B2 (AU)
Title: Treatment or reduction of dental conditions with ascorbyl esters
Inventor: SCHERL DALE S
IPC: A23K1/00
Filed: 2011-12-21
Granted: 2014-10-30
Abstract: The present disclosure provides methods and compositions comprising ascorbyl esters for the treatment or reduction of dental conditions in an animal. A pet food composition of the disclosure can be a dry food composition comprising (i) a matrix of ingredients nutritionally or organoleptically adapted for the animal and (ii) an outer coating layer, wherein the outer coating layer is applied to the matrix as a solution comprising an effective amount of an ascorbic acid fatty acid ester dissolved in a plant oil. One disclosed method of treatment or reduction involves feeding an animal in need of such treatment a dry pet food composition of the disclosure. A second disclosed method comprises applying to one or more surfaces of one or more teeth of an animal in need of such treatment, an effective amount of a solution comprising an ascorbic acid fatty acid ester dissolved in a plant oil.